Publications | Lund University Publications

301 – 310 of 350

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22PROSTATE+CANCER%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
30
31
32
33
…
35
next »

2006
Mark Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
Kalkner, Karl Mikael ; Acosta, Stefan ^LU ; Thorsson, Ola ^LU ; Frederiksen, Hans ^LU ; Nilsson, A ; Gustavsson, Bengt ; Elingsbo, Marie ; Stridsberg, M and Abrahamsson, Per-Anders ^LU (2006) In Prostate Cancer and Prostatic Diseases 9(1). p.92-98
- Contribution to journal › Article
Mark Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
Tyrrell, Chris J. ; Iversen, Peter ; Tammela, Teuvo ; Anderson, John ; Björk, Thomas ^LU ; Kaisary, Amir V. and Morris, Thomas (2006) In BJU International 98(3). p.563-572
- Contribution to journal › Article
Mark Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
Steuber, T ; Vickers, AJ ; Haese, A ; Becker, Charlotte ^LU ; Pettersson, K ; Chun, FKH ; Kattan, MW ; Eastham, JA ; Scardino, PT and Huland, H , et al. (2006) In International Journal of Cancer 118(5). p.1234-1240
- Contribution to journal › Article
Mark Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
Isaacs, J T ; Pili, R ; Qian, D Z ; Dalrymple, S L ; Garrison, J B ; Kyprianou, N ; Bjork, A ; Olsson, A and Leanderson, Tomas ^LU (2006) In The Prostate 66(16). p.1768-1778
- Contribution to journal › Article
Mark CYSTATIN C AND NEUROENDOCRINE DIFFERENTIATION IN THE MALE REPRODUCTIVE SYSTEM AND IN PROSTATE CANCER
Jiborn, Thomas ^LU (2006)
- Thesis › Doctoral thesis (compilation)
Mark Hormone therapy: Improving therapy decisions and monitoring
Zlotta, AR ; Abrahamsson, Per-Anders ^LU ; Tombal, B ; Berges, R and Debruyne, F (2006) In European Urology. Supplement 5(3). p.369-376
- Contribution to journal › Article
Mark The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
Teillac, Pierre and Abrahamsson, Per-Anders ^LU (2006) In European Urology. Supplement 5(9). p.640-646
- Contribution to journal › Article
Mark Solution structures of human and porcine beta-microseminoprotein
Ghasriani, Houman ^LU ; Teilum, Kaare ^LU ; Johnsson, Ylva ; Fernlund, Per ^LU and Drakenberg, Torbjörn ^LU (2006) In Journal of Molecular Biology 362(3). p.502-515
- Contribution to journal › Article
2005
Mark A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
Wegiel, Barbara ^LU ; Bjartell, Anders ^LU ; Ekberg, Jenny ^LU ; Gadaleanu, Virgil ; Brunhoff, Cecilia ^LU and Persson, Jenny L ^LU (2005) In Oncogene 24(42). p.6385-6393
- Contribution to journal › Article
Mark Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
Steuber, T ; Niemela, P ; Haese, A ; Pettersson, K ; Erbersdobler, A ; Chun, K H F ; Graefen, M ; Kattan, M W ; Huland, H and Lilja, Hans ^LU (2005) In The Prostate 63(1). p.13-18
- Contribution to journal › Article

« previous
1
…
30
31
32
33
…
35
next »

your query:: Remove keywords: PROSTATE CANCER